Cardiac amyloidosis - Cardiovascular magnetic resonance imaging as a valuable diagnostic tool;Kardiale amyloidose - Kardio-MRT als hilfreiches diagnostisches Werkzeug

Deutsche Medizinische Wochenschrift

Volumn 134, Issue 15, 2009, Pages 734-737

  Braun, G ^a   Sechtem, U ^a   Mahrholdt, H ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Amyloidosis; Cardiomyopathy; Magnetic resonance imaging

Indexed keywords

GADOLINIUM; PREALBUMIN; AMYLOID; TRANSTHYRETIN RELATED AMYLOID FIBRIL PROTEIN, HUMAN; TRANSTHYRETIN-RELATED AMYLOID FIBRIL PROTEIN, HUMAN;

AGED; AORTA PRESSURE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CASE REPORT; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EMERGENCY WARD; HEART AMYLOIDOSIS; HEART FAILURE; HEART MUSCLE BIOPSY; HEART VENTRICLE HYPERTROPHY; HOSPITAL DISCHARGE; HUMAN; IMAGE ENHANCEMENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SYMPTOM; AMYLOIDOSIS; AORTA VALVE; DIFFERENTIAL DIAGNOSIS; GENETICS; HEART DISEASE; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY;

AGED, 80 AND OVER; AMYLOID; AMYLOIDOSIS; AORTIC VALVE; AORTIC VALVE STENOSIS; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; PREALBUMIN;

EID: 64549083621     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1220221     Document Type: Article

References (10)

1. Bonow RO, Carabello BA, Chatterjee K et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118: e523-e661
2. Falk R. Diagnosis and management of the cardiac amyloidosis. Circulation 2005; 112: 2047-2060
3. Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. NEJM 2000; 343: 1445-1453
4. Kupfahl C, Honold M, Meinhardt G et al. Evaluation of aortic stenosis by cardiovascular magnetic resonance imaging: comparison with established routine clinical techniques. Heart 2004; 90: 893-901
5. Mahrholdt H, Goedecke C, Wagner A et al. Cardiovascular magnetic resonance assessment of human myocarditis. Circulation 2004; 109: 1250-1258
6. Mahrholdt H, Wagner A, Judd RM et al. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J 2002; 23: 602-619
7. Mahrholdt H, Wagner A, Judd RM et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005; 26: 1461-1474 (Pubitemid 41373486)
8. Moon JC, McKenna WJ, McCrohon JA et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003; 41: 1561-7
9. Ricciardi MJ, Wu E, Davidson CJ et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001; 103: 2780-2783
10. Vogelsberg H, Mahrholdt H, Deluigi CC et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis. J Am Coll Cardiol 2008; 51: 1022-1030